ProFound AI for Digital Breast Tomosynthesis

iCAD

The concurrent-read, cancer detection and workflow solution from iCAD analyzes each tomosynthesis image, detecting both malignant soft tissue densities and calcifications.
Built on deep-learning and artificial intelligence technology, ProFound AI for breast tomosynthesis assists radiologists in addressing the challenges of reading tomosynthesis.

Formerly branded as PowerLook Tomo Detection 2.0
Product specifications Information source: Vendor
Last updated: July 16, 2020
General
Product name ProFound AI for Digital Breast Tomosynthesis
Company iCAD
Subspeciality Breast
Modality Mammography
Disease targeted breast cancer
Key-features malignancy detection, calcification detection, certainty scoring, case scoring
Suggested use Before: adapting worklist order
During: perception aid (prompting all abnormalities/results/heatmaps)
Data characteristics
Population Asymptomatic screening population
Input 3D Digital Breast Tomosynthesis
Input format DICOM
Output Leasion score with segmentation overlay, case score, choice in sensitivity (high/med/low)
Output format DICOM Structured Report, GSPS, Secondary Capture
Technology
Integration Integration in standard reading environment (PACS), Stand-alone third party application, Provides case score in worklist when applicable
Deployment Locally on dedicated hardware
Trigger for analysis Automatically, right after the image acquisition
Processing time 1 - 10 minutes
Certification
CE Certified, Class IIa
FDA 510(k) cleared, Class II
Market presence
On market since 03-2018
Distribution channels
Countries present (clinical, non-research use) 19
Paying clinical customers (institutes) 1000+
Research/test users (institutes) 30+
Pricing
Pricing model
Based on
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance

  • Artificial Intelligence for Digital Breast Tomosynthesis - Reader Study Results (read)
Other relevant papers